Interventional neurology is a specialty that uses minimally invasive, image-guided techniques to treat most of the complex and dangerous diseases of the brain, neck, and spine. Education and research are the main components of the interventional neurology services. The procedures performed by the interventional neurologists are complex. The primary aim is to minimize the risk to the patient by application of image guidance and minimally invasive techniques. The interventional neurologists specialize in the manipulation of needles and the use of fine catheter tubes and wires to navigate around the body using imaging control.
Technavio’s analysts forecast the global interventional neurology devices market to grow at a CAGR of 7.50% during the period 2017-2021.
Covered in this report The report covers the present scenario and the growth prospects of the global interventional neurology devices market for 2017-2021. To calculate the market size, the report considers the total sales volume and revenue generated from interventional neurology devices.
The market is divided into the following segments based on geography: • Americas • APAC • EMEA
Technavio’s report, Global Interventional Neurology Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Other prominent vendors • Acandis • B. Braun Melsungen • Bayer • Boston Scientific • Biosensors International • evonos • Merit Medical Systems • MicroPort Scientific • Neurosign • Penumbra • Spiegelberg • Surtex Instruments • W. L. Gore & Associates
Market driver • Increase in incidence of neurological disorders • For a full, detailed list, view our report
Market challenge • Inadequate and inequitably distributed resources • For a full, detailed list, view our report
Market trend • Increased funding for R&D of neurotherapies • For a full, detailed list, view our report
Key questions answered in this report • What will the market size be in 2020 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Our reports have been used by over 10K customers, including:
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Sleep Market Report
The sleep market by revenue is expected to grow at a CAGR of 6.11% during the period 2020–2026.
Several research studies and government programs help improve awareness explaining the importance of sleep in many countries.
Giving support: Funding increases should help the industry recover from current-year disruption Abstract Learning Disability, Mental Health & Substance Abuse Facilities in the UK Operators in this industry provide residential care for people with learning disabilities, mental illness or substance abuse...
Aiding care: Emergency funding to counteract the effects of COVID-19 is expected to support industry revenue Abstract Domiciliary Care in the UK Companies operating in the Domiciliary Care industry provide intensive, at-home nursing care to patients. Residential nursing care activities are excluded...
North America, the narcolepsy market, is anticipated to reach US$ 2,024.8 Mn in 2027 from US$ 919.6 Mn in 2018. The market is projected to grow with a CAGR of 9.3% from 2019-2027. The narcolepsy market is expected to grow due to key driving factors such as rising sleep disorders and growing pharmaceutical industry.The market is divided...
The global narcolepsy market is expected to reach US$ 4,537.9 Mn in 2027 from US$ 2,026.8 Mn in 2018. The market is estimated to grow with a CAGR of 9.5% from 2019-2027. The growth of the narcolepsy market is primarily attributed to the rising prevalence of sleep related neurological disorders, emerging local pharmaceutical and biopharmaceutical...
Innovation Tracking Factbook 2018: An Assessment of the Pharmaceutical Pipeline Summary Innovation in developing new products is the key element in growth in the pharmaceutical industry.The market is highly research-intensive, powered by high R&D investment, and it possesses a strong product pipeline...
Summary Population Diagnostics Inc (Population Diagnostics) is a biotechnology company that carries out the research, development and discovery of platform technology for validation of causative genetic biomarkers. The company develops various therapeutic areas such as novel targeted drugs, drug rescue of Phase II & III failures,...
Summary LineaGen Inc (LineaGen), formerly GenData Research Corporation is a healthcare services provider that includes diagnostic service. The company provides diagnostic evaluation services for complex diseases. Its offers testing services such as FirstStepDx PLUS chromosomal micro array which detect deletions and duplication...
Health Care Provider
Salt Lake County
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.